Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis - PubMed (original) (raw)
Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis
M Filippi et al. Neurology. 2010.
Abstract
Objective: To generate and validate new MRI diagnostic criteria for multiple sclerosis (MS) taking into account not only white matter lesions but also intracortical lesions (ICLs).
Methods: Brain double inversion recovery and brain and cord T2- and postcontrast T1-weighted scans were acquired in a training (80 patients with clinically isolated syndromes [CIS], median follow-up = 55.3 months) and a validation (39 patients with CIS, median follow-up = 28.0 months) sample. In the training sample, regression analysis and Cox proportional hazard model were used to identify MRI variables independently predicting the evolution to clinically definite (CD) MS. The best criterion selected was then validated. The performance of the new and previously available MRI criteria for disease dissemination in space (DIS) and time (DIT) were tested.
Results: The final multivariate model showed that ≥1 ICL (p < 0.001), ≥1 infratentorial (p = 0.03), and ≥ 1 gadolinium-enhancing or ≥1 spinal cord lesion (p = 0.004) were independent predictors of CDMS. The presence of at least 2 of these variables was the best DIS criterion in both samples. New ICLs had a poor sensitivity for DIT. The combination of the new DIS criterion with the MAGNIMS criteria for DIT yielded to an accuracy of 81%, which was higher than those of the other available criteria.
Conclusions: The accuracy of MRI diagnostic criteria for MS is increased when considering the presence of ICLs on baseline scans from patients at presentation with CIS suggestive of MS. If confirmed by other studies, ICL detection might be considered in future diagnostic algorithms for MS.
Similar articles
- MS cortical lesion or not? Double inversion recovery MRI reveals some answers and uncertainties.
Chen JT, Pirko I. Chen JT, et al. Neurology. 2011 Feb 1;76(5):412-3. doi: 10.1212/WNL.0b013e31820a0d6e. Epub 2011 Jan 5. Neurology. 2011. PMID: 21209372 No abstract available. - Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
Sepulcre J, Goñi J, Masdeu JC, Bejarano B, Vélez de Mendizábal N, Toledo JB, Villoslada P. Sepulcre J, et al. Arch Neurol. 2009 Feb;66(2):173-9. doi: 10.1001/archneurol.2008.562. Arch Neurol. 2009. PMID: 19204153 - Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis.
Calabrese M, De Stefano N, Atzori M, Bernardi V, Mattisi I, Barachino L, Morra A, Rinaldi L, Romualdi C, Perini P, Battistin L, Gallo P. Calabrese M, et al. Arch Neurol. 2007 Oct;64(10):1416-22. doi: 10.1001/archneur.64.10.1416. Arch Neurol. 2007. PMID: 17923625 - The role of MRI in the diagnosis of multiple sclerosis.
Traboulsee AL, Li DK. Traboulsee AL, et al. Adv Neurol. 2006;98:125-46. Adv Neurol. 2006. PMID: 16400831 Review. - Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging.
Chard D, Miller D. Chard D, et al. J Neurol Sci. 2009 Jul 15;282(1-2):5-11. doi: 10.1016/j.jns.2009.01.012. Epub 2009 Feb 6. J Neurol Sci. 2009. PMID: 19201002 Review.
Cited by
- Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis.
Rocca MA, Preziosa P, Barkhof F, Brownlee W, Calabrese M, De Stefano N, Granziera C, Ropele S, Toosy AT, Vidal-Jordana À, Di Filippo M, Filippi M. Rocca MA, et al. Lancet Reg Health Eur. 2024 Aug 22;44:100978. doi: 10.1016/j.lanepe.2024.100978. eCollection 2024 Sep. Lancet Reg Health Eur. 2024. PMID: 39444702 Free PMC article. Review. - A novel imaging marker of cortical "cellularity" in multiple sclerosis patients.
Barakovic M, Weigel M, Cagol A, Schaedelin S, Galbusera R, Lu PJ, Chen X, Melie-Garcia L, Ocampo-Pineda M, Bahn E, Stadelmann C, Palombo M, Kappos L, Kuhle J, Magon S, Granziera C. Barakovic M, et al. Sci Rep. 2024 Apr 29;14(1):9848. doi: 10.1038/s41598-024-60497-6. Sci Rep. 2024. PMID: 38684744 Free PMC article. - The astrocyte-produced growth factor HB-EGF limits autoimmune CNS pathology.
Linnerbauer M, Lößlein L, Vandrey O, Peter A, Han Y, Tsaktanis T, Wogram E, Needhamsen M, Kular L, Nagel L, Zissler J, Andert M, Meszaros L, Hanspach J, Zuber F, Naumann UJ, Diebold M, Wheeler MA, Beyer T, Nirschl L, Cirac A, Laun FB, Günther C, Winkler J, Bäuerle T, Jagodic M, Hemmer B, Prinz M, Quintana FJ, Rothhammer V. Linnerbauer M, et al. Nat Immunol. 2024 Mar;25(3):432-447. doi: 10.1038/s41590-024-01756-6. Epub 2024 Feb 26. Nat Immunol. 2024. PMID: 38409259 Free PMC article. - Emerging imaging markers in radiologically isolated syndrome: implications for earlier treatment initiation.
Moura J, Granziera C, Marta M, Silva AM. Moura J, et al. Neurol Sci. 2024 Jul;45(7):3061-3068. doi: 10.1007/s10072-024-07402-1. Epub 2024 Feb 19. Neurol Sci. 2024. PMID: 38374458 Review. - Interrater reliability for the detection of cortical lesions on phase-sensitive inversion recovery magnetic resonance imaging in patients with multiple sclerosis.
de Caneda MAG, Rizzo MRL, Furlin G, Kupske A, Valentini BB, Ortiz RF, Silva CBO, de Vecino MCA. de Caneda MAG, et al. Radiol Bras. 2023 Jul-Aug;56(4):187-194. doi: 10.1590/0100-3984.2022.0116. Radiol Bras. 2023. PMID: 37829590 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical